BNP-32, Rat, ELISA Kit, AssayMax (96 well)

• 商品コード：ERB1201-1
• メーカー：ANG
• 包装：1kit
• 価格： ¥77,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Bodyak N et al. (2007) Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 104(43):16810-16815
  
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  Onai Y et al. (2007) Inhibition of NF-?B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 292(1): H530-H538
  
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Rohrbach S et al. (2008) Enhanced myocardial vitamin C accumulation in left ventricular hypertrophy in rats is not attenuated with transition to heart failure. European Journal of Heart Failure 10:226-232
  
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Bayir Y et al. (2009) Effects of Lacidipine, Ramipril and Valsartan on Serum BNP Levels in Acute and Chronic Periods Following Isoproterenol-Induced Myocardial Infarction in Rats. The Eurasian Journal of Medicine 42:45-48
  
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Prathapan A et al. (2013) Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-?Beta and transforming growth factor beta1. British Journal of Nutrition. 1
  
  
• 備考：
  
• 参照：
  

• No.： 6
• 文献情報：
  Yang S et al. (2013) Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy? Med Sci Monit Basic Res. 19: 20-31
  
  
• 備考：
  
• 参照：
  

• No.： 7
• 文献情報：
  Aritomi S et al. (2015) Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats. Clin Exp Pharmacol Physiol. 42(4):344-52
  
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  Bae S et al. (2011) Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res 91(4):632-639
  
  
• 備考：
  
• 参照：
  

• No.： 9
• 文献情報：
  Wang X et al. (2010) Pharmacogenomic, Physiological and Biochemical Investigations on Safety and Efficacy Biomarkers Associated with the PPAR? Activator, Rosiglitazone, in Rodents: a Translational Medicine Investigation.
  
  
• 備考：
  
• 参照：
  

• No.： 10
• 文献情報：
  Leychenko A et al. (2011) Stretch-Induced Hypertrophy Activates NFkB-Mediated VEGF Secretion in Adult Cardiomyocytes. PLoS One. 6(12): e29055
  
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Maejima Y et al. (2011) Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma. Laboratory investigation a journal of technical methods and pathology. 91(6): 932-944
  
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Bharti S et al. (2012) Phosphorylation of Akt/GSK-3Beta/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats. FEBS Letters 586(2):180-185
  
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Atalay C et al. (2010) The efficacy of spironolactone in the treatment of acute respiratory distress syndrome-induced rats. Singzpore Med J. 51:501-505
  
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Kelher MR et al. (2009) Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 113: 2079-2087
  
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Wang XH et al. (2012) Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1? in volume-overloaded rats with heart failure. J Geriatr Cardiol. 9(2): 172・79
  
  
• 備考：
  
• 参照：